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A B S T R A C T
Objective: To evaluate the use of patient self-completion concordance forms and to determine the effect
of patient counselling by using concordance forms on adherence to chronic medication.
Methods: Patients with a prescription for new chronic treatment were randomised in an intervention or
control group. The intervention group received a concordance form to ﬁll in at home and to discuss
during a consultation 2 weeks later in the pharmacy. The control group received the usual information
and instruction on how to use the medicine. Afterwards, all patients were asked to ﬁll in a questionnaire
about their use of medicines and contact with the pharmacy employees. Adherence to the medicine was
determined using rates of prescription reﬁlls after 6 months of use.
Results: The questionnaires showed that patients were satisﬁed about the concordance model. After 6
months of use, 79% of the patients from both intervention and control group were deﬁned as adherent.
Conclusions: There was no signiﬁcant difference found in adherence between intervention and control
group.
Practice implications: Use ﬁve selected questions from the concordance form which provided most
answers. Focus on one drug group and have more consultation moments.
 2009 Elsevier Ireland Ltd. All rights reserved.
Contents lists available at ScienceDirect
Patient Education and Counseling
journa l homepage: www.e lsev ier .com/ locate /pateducou1. Introduction
Adherence to chronic medication is important for effective
treatment. However, poor adherence is a signiﬁcant problem for
chronic medication use. According to the literature, the adherence
to medication in developed countries is 50% after 1 year [1–3]. To
reach a higher degree of adherence, it is important to involve the
patient in a decision about starting (chronic) therapy [4].
According to Barnett et al. [5], patient participation in
medication counselling is a necessary element for the provision
of pharmaceutical care. Motivating patients to write down
questions to ask the pharmacist results in more patient and
pharmacist satisfaction with the information given. During
communication with doctors, patients lack the opportunity to
express their concerns, expectations, and beliefs [6]. Therefore, the
more questions doctors ask the more content patients are with* Corresponding author at: Antonius Deusinglaan 1, 9713 AV Groningen, The
Netherlands. Tel.: +31 (0)50 363 25 78; fax: +31 (0)50 363 27 72.
E-mail address: m.m.e.geurts@rug.nl (Marlies M.E. Geurts).
0738-3991/$ – see front matter  2009 Elsevier Ireland Ltd. All rights reserved.
doi:10.1016/j.pec.2009.04.005their medication. Another study [7] describes the effect of
encouraging patients to raise issues and to discuss symptoms
and other health-related issues during a consultation with a
general practitioner. Patients were provided with a leaﬂet to write
down questions to ask the doctor, which improved patient
satisfaction and perceptions of communication.
In the Netherlands, community pharmacies have changed from
product-centred to more patient-centred activities [8,9]. The
patient receives extensive information at the time of the initial
prescription. Yet patients immediately forget 40–80% of this
medical information [10]. This means it would be desirable to
repeat certain information and provide feedback to help the
patient remember. It is also important to discuss the indications of
the medicine with the patient, in order to understand the
importance of the medicine for their wellbeing. The pharmacist
is, in most cases, the last professional the patient meets before
actually starting to take the new medicine. Therefore, the
pharmacist is the appropriate professional to answer any
remaining questions the patient has about the medication.
Furthermore, a study performed in Dutch community pharmacies
concluded that patients whowere asked to ﬁll in a form about their
Table 2
Questions on the concordance form.
1. What are your expectations about the use of this medicine?
2. What concerns do you have regarding this medicine?
3. What problems did you experience using this medicine?
4. What do you notice of this medicine?
5. What would you like to know about this medicine?
6. What would you like to know about the use of this medicine?
7. What would be a reason for you to stop using this medicine?
8. What opinion do family, friends and neighbours have about using
this medicine?
9. Is this the ﬁrst time you get medicines to use for a longer time
(more than 3 months)? yes/no
If no, please mention the medicine by name?
10. Do you have any comments or questions?
11. How much time did it take to ﬁll in this form?
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pharmacy [11].
Hamilton et al. [12] studied the use of patient self-completion
agenda forms on prescribing and adherence in general practice.
The use of patient self-completion agenda forms followed by a
consultation can be regarded as kind of balance sheet, as described
by Janis and Mann [13]. After the consultation, where the patient
receives information about the use of the medicine, the use can be
discussed. Based on the advantages and disadvantages, the quality
of the decision to use the medicine is increased. It is expected that
this will be expressed in patient adherence to the medicine. We
developed a patient self-completion agenda form for use in
community pharmacy practice, the so-called concordance form.
The aim of this study is to evaluate the use of patient self-
completion concordance forms and patient consultations in the
pharmacy using the form, and to determine the effect of the form
and consultation on a patient’s adherence to chronic medication.
2. Methods
The independent Ethics Committee in Leeuwarden determined
that this study posed no risk to patients. The committee concluded
that the Dutch law for protecting patients, who are included in a
clinical trial is not relevant to this study protocol. Therefore further
review was not required.
Eighteen community pharmacies, located across the Nether-
lands, were included. For each pharmacy, one or more employees
(at least one pharmacist) took a course on treating patients in
accordance with the concordance model. From May until
December 2006, patients were selected according to the below
mentioned inclusion and exclusion criteria.
Inclusion criteria:
 ﬁrst prescription for newmedicine for chronic use from selected
drug class (Table 1);
 minimum age 18 years;
 consent from patient.
Exclusion criteria:
 no opportunity to guide patients personally (for example
patients in nursing home);





A02 Drugs for acid related disorders
A07 Antidiarrheals, intestinal anti-inﬂammatory/antiinfective agents






C07 Beta blocking agents
C08 Calcium channel blockers
C09 Agents acting on the rennin–angiotensin system









R03 Drugs for obstructive airway diseasesPatients were recruited according to an application for ﬁrst and
second dispensing in the pharmacy computer system. The selected
drug classes are mentioned in Table 1. The pharmacy determined
which groups of medicines this application was used. Before the
start of the study a unique numberwas assigned to all patients from
the selected pharmacies.When patients were included according to
the inclusion criteria they were randomised by the pharmacy
computer system in the intervention or control group. Patients with
an even number were included in the intervention group, patients
with an odd number were included in the control group.
The intervention group received the usual information and
instruction and a concordance form (Table 2) with questions to ﬁll
in at home after the ﬁrst dispensing of the medicine. Open ended
questions were used to ask for patients opinion about their use of
medicines. At the second dispensing, after 2 weeks, a pharmacy
employee used the completed concordance form as a basis for a
patient consultation. The control group received the usual
information and instruction on how to use the medicine during
the ﬁrst and second dispensing (Fig. 1).
In the ﬁrst part of the study, the authors hypothesized that the
concordance model will create improved patient satisfaction with
medicines. To explore this hypothesis, we used a patient
questionnaire. After the second dispensing of the medicine, both
patient groups received a questionnaire to ﬁll in at home. The
questionnaire contained 12 closed questions, using an explicit
format varying from 4 to 7 points. The patient was asked to mark
the answer which most closely matches what they think about the
proposition deﬁned in the question. The questionnaire included
questions about contact with the pharmacist or pharmacy
technician as well as the advantages or disadvantages of
medication use.
In the second part of the study, the authors hypothesized that
extra guidance with a concordance consultation during the second
dispensing of the medicine would increase adherence to that
medicine after 6months. Patients were asked for consent to collect
data from the pharmacy computer system concerning dates on
prescription reﬁlls. Patients using inhalers for asthma or insulin for
diabetes; who stopped using the prescribed medicine after
consultation with the general practitioner; or who moved and
went to another pharmacy to receive their medicines were
excluded for this part of the analysis because it was not possible
to calculate accurate adherence. After 6 months of use, the
adherence was calculated using rates of prescription reﬁlls [4]. We
divided the number of days the patient received the medicine
supply from the pharmacy by the number of days themedicinewas
prescribed. The patient was deﬁned as adherent if the calculated
medicinal drug use was 75% according to prescribed drug use. A
selection of the patients also received a second questionnaire
about the use of medicine after 6 months. The aim of this
questionnaire was to assess reasons for possible non-adherence to
the medicine.
Fig. 1. Study design.
Table 3
Time needed to ﬁll in the concordance form.








Location where the consultation took place.
Location N %
Counter 9 5.6
Consultation room 126 78.3
Ofﬁce pharmacist 24 14.9
At patients home 1 0.6
By phone 1 0.6
Total 161 100.0
Table 5
Time needed for the consultation.
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The results were analysed using SPSS 12.0.1 for Windows.
Means of the intervention and control group were compared using
independent samples t-test. The questions on the patient
questionnaire were clustered calculating Cronbach’sa. Differences
in adherence between the two groups were tested by a chi-square
test.
The sample size calculation was based on the outcome
adherence to chronic medication. The expected proportion
adherent patients after 6 months in the control group was
estimated to be 60% and expected to be 75% for the intervention
group. For 80% power, with a one-sided 5% a, 120 patients were
required in each group to identify this difference.
2.2. Privacy
All concordance forms and questionnaires were labelled with
only a unique patient number in order to protect patients’ privacy.
3. Results
The response rate for the patient questionnaire was 45% in the
intervention group and 41% in the control group. Patients who did
not return the questionnairewere excluded. After exclusion, a total
of 521 patients remained, 250 patients in the intervention group
and 271 patients in the control group. Side effects were mentioned
mostly as possible concerns or problems on the concordance form.
Other patient interests were in combination with other medicines:
if it is possible to stop using themedicine at a certain time, and how
long the medicine should be used. Further patient comments
mostly contained comments about or answers to questions posed
in the questionnaire. General comments about the concordance
model were all positive.
The written answers on the concordance forms showed that
there were ﬁve questions that provided most answers and were
considered most relevant:
1. What are your expectations about the use of this medicine?
2. What would you like to know about this medicine?
3. What problems did you experience using this medicine?
4. What concerns do you have regarding this medicine?
5. What would be a reason for you to stop using this medicine?
The patients were also asked howmuch time they needed to ﬁll
in the concordance form. These results are presented in Table 3.
After the consultation with the patient, the pharmacist was
asked where the consultation with the patient had taken place andhowmuch time it took. Results are presented in Tables 4 and 5. The
total number of patients is different in these tables because not all
information was available for each patient.
Table 6 shows the questions and the percentage response for
each possible answer from the patient questionnaire.
Using Cronbach’s a calculation, the questions were clustered
into four groups: evaluation, attitude advantages, own effective-
ness, and attitude disadvantages. There was no signiﬁcant
difference observed in the concordance model for the intervention
group (P-value for each clustered group >0.2).
For the second part of this study, data from the pharmacy
computer system was collected to calculate patient adherence to
themedicine. After consent and exclusion of 52 patients, according
to the exclusion criteria, 448 patients remained for analysis. 235 of
the 448 included patients were in the intervention group with a
mean (S.D.) age of 61.4 (14.9) years. In the control group were 213
patients with a mean (S.D.) age of 60.0 (14.1) years. The deﬁnition
of adherence was set to a calculated drug use of75% according to
prescribed drug use. In both intervention and control group, 79% of
the patients were deﬁned as adherent. The difference was not
statistically signiﬁcant (P > 0.2).
The second questionnaire, whichwas sent to 281 patients, had a
response rate of 51%. The ﬁrst question asked which drug for
chronic use the patient started 6 months ago. 63% of all
respondents gave the right drug name, 24% did not answer this
question, and 13% mentioned another drug name. Only the
questionnaires from patients who ﬁlled in the right drug name
were analysed. The second question asked if the patient still uses
the medicine at the present time. A few patients (12%) mentioned
that they stopped using the medicine. Data from the pharmacy
computer system showed that not all patients actually stopped
using the medicine but were switched to another medicine. The
Table 6
Patient questionnaire (N = 521).
Question Answer categories: number
of patients (%)
Evaluation (a = 0.7425)
1. I appreciate the attention from
the pharmacist/pharmacy technician.
Yes very much: 218 (41.8%)
Yes: 278 (53.4%)
Yes a little: 7 (1.3%)
Neutral: 17 (3.3%)
No not really: 1 (0.2%)
No: 0 (0%)
No absolutely not: 0 (0%)
Not answered: 0 (0%)
2. I think the consultation with
the pharmacist is useful for me.
Yes very useful: 164 (31.5%)
Yes useful: 309 (59.3%)
Yes a little useful: 32 (6.1%)
No not useful: 6 (1.2%)
Not answered: 10 (1.9%)
3. The pharmacist gave me
information which I can use.
Yes much: 321 (61.6%)
Yes a little: 129 (24.8%)
Yes very little: 25 (4.8%)
No: 15 (2.9%)
Not answered: 31 (6.0%)
Attitude advantages (a = 0.8318)
4. I think I need medication in
general for my disease.
Yes deﬁnitely: 272 (52.2%)
Yes: 169 (32.4%)
Yes probably: 56 (10.7%)
Neutral: 16 (3.1%)
No probably not: 1 (0.2%)
No: 5 (1.0%)
No deﬁnitely not: 0 (0%)
Not answered: 2 (0.4%)
5. I am convinced I need this medicine. Yes deﬁnitely: 211 (40.5%)
Yes: 194 (37.2%)
Yes probably: 86 (16.5%)
Neutral: 16 (3.1%)
No probably not: 7 (1.3%)
No: 4 (0.8%)
No deﬁnitely not: 0 (0%)
Not answered: 3 (0.6%)
6. The use of this medicine
according to the prescription
shows advantages for me
(e.g. less complaints, I feel
better/stronger, I can do
more activities).
Yes much: 99 (19.0%)
Yes: 263 (50.5%)
Yes a few: 64 (12.3%)
No: 76 (14.6%)
Not answered: 19 (3.6%)
7. I think the advantages
counts the disadvantages.
Yes absolutely: 127 (24.4%)
Yes: 271 (52.0%)
Yes a little: 65 (12.5%)
No: 33 (6.3%)
Not answered: 25 (4.8%)
8. The choice for this medicine
was for me personally the
best choice.
Yes the best choice: 48 (9.2%)
Yes a good choice: 302 (58.0%)
Yes a reasonably choice: 111 (21.3%)
No a less good choice: 12 (2.3%)
No a bad choice: 5 (1.0%)
No the worst choice: 2 (0.4%)
Not answered: 41 (7.9%)
Own effectiveness (a = 0.6418)
9. I think I will manage to use
the medicine according the
text on the label.
Yes deﬁnitely: 444 (85.2%)
Table 6 (Continued )
Question Answer categories: number
of patients (%)
Yes probably: 63 (12.1%)
No probably not: 4 (0.8%)
No deﬁnitely not: 6 (1.2%)
Not answered: 4 (0.8%)
10. I think it is important to use
this medicine according the
text on the label.
Yes very important: 302 (58.0%)
Yes important: 197 (37.8%)
Yes a little important: 13 (2.5%)
No not important: 4 (0.8%)
Not answered: 5 (1.0%)
Attitude disadvantages (a = 0.6368)
11. If I use this medicine according
the prescription this will have
disadvantages for me (e.g. side
effects, administration route).
Yes big advantages: 17 (3.3%)
Yes advantages: 79 (15.2%)
Yes a few advantages: 122 (23.4%)
No advantages: 292 (56.0%)
Not answered: 11 (2.1%)
12. I am afraid of side effects
from this medicine.
Yes very: 17 (3.3%)
Yes: 39 (7.5%)
Yes a little: 152 (29.2%)
No: 302 (58.0%)
Not answered: 11 (2.1%)
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all in agreement with the data from the pharmacy computer
system. The patients who stopped or switched using the medicine
were asked why they stopped or switched and most answers were
related to side effects.
4. Discussion and conclusion
4.1. Discussion
The questions on the concordance form were used by the
pharmacist to start the patient consultation. The answers on the
questions show the patients’ needs for extra information. Concerns
about possible side effects werementionedmost in answers on the
concordance form. This shows that patients have a need for extra
information on side effects, and this will be one of the main topics
discussed in the consultation. Question 10, do you have any
comments or questions, did not provide extra comments or
questions in addition to the answers already given on the
concordance form. If patients made comments on the concordance
form, they were all positive. This shows that patients are positive
about the use of the concordance form as part of the concordance
model at the moment they start using chronic medication. Most
patients needed a maximum of 10 min to ﬁll in the concordance
form; the extra load was not too high.
The advice given in the course for pharmacy employees was to
have the consultation with the patient in a consultation room in
the absence of other patients for optimal privacy. More than 90% of
the consultations took place in a separate room, either a
consultation room or the pharmacists ofﬁce.
The time needed for the patient consultationwas expected to be
10 min. The use of the concordance form in the consultation was a
new experience for the pharmacist and his/her team. Almost 50% of
the consultations took more time than the expected 10 min. It was
expected that the consultationswould take less time once the team
had gained more experience with the method. Some pharmacists
also mentioned that the consultations took more time because
patients had questions about medications other than the medicine
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patients have unanswered questions about their medicines. Thus
these consultations with the pharmacist seemed to be useful.
A patient questionnaire was used to measure how patients
think about their use ofmedicines. No signiﬁcant result was shown
for the use of the concordance model. This could be explained by
the selection of patients who use medicines from different groups.
It was possible that, for example, patients with diabetes thought
differently about the use of their medicines compared to patients
who use medication to treat hypertension. In this study, the
number of patients was too small to make a division into different
drug groups.
The experiences of participating pharmacy employees showed
that the implementation of the concordance model does not cause
any problems. The use of the concordance formwas experienced as
a newway of contacting the patient, and thiswasmentioned by the
participants as positive. Pharmacists initially noted that the
interaction with the patients according to the concordance form
was a bit uncomfortable but that changedwhen they becamemore
experienced. The use of the concordance form was mentioned as
being useful in initiating the consultation with the patient. The
pharmacists experienced the active consultation as pleasant and
positive according to the patient.
In the second part of the study, adherence after 6 months of use
was calculated. It was expected that the intervention group would
have a higher percentage of adherent drug users than the control
group. The percentage of adherent drug users in the control group
was in fact remarkably high. From previous studies, the authors
expected the adherence after 6 months to be 60% [1–3]. We
hypothesized that consultations would increase adherence as had
been previously reported. Gourley et al., for example, showed that
for hypertensive patients receiving ﬁve consultations over a period
of 6 months was more effective on adherence and general health
than receiving just two consultations in the same time period [14].
One explanation forwhy our results did notmatch those of Gourley
et al. could be that there was only one consultation in our study. A
possible explanation for the high percentage of adherence in the
control group was that the pharmacies were not randomly
selected. There was an open call for recruitment, which probably
attracted more motivated pharmacists. All the pharmacies were
already providing pharmaceutical care using protocols for ﬁrst and
second dispensing, so the difference between the intervention and
control group may possibly be smaller. When the adherence in the
control group was already 79% it would be difﬁcult to improve. A
second explanation could be the difference in providing informa-
tion to the patients within the two groups. All pharmacies had
patients included in both intervention and control group. Because
this was a new way of providing pharmaceutical care and the
pharmacists took a course in concordance, it could be that patients
in the control group also received care according to the
concordance model because they were treated different compared
to usual care. Third, it was difﬁcult to measure if each pharmacist
used the concordance model the same way. Because the course on
concordance only took two half days, it was possible that some
pharmacists were more skilled using the concordance model than
other pharmacists who took the same course.
The adherence was calculated using rates of prescription reﬁlls.
This was an objective method with easily obtained data. A
disadvantage of this method was that the rate of prescription reﬁll
was not equivalent to ingestion of the medicine by the patient.
Another disadvantage was that we could not be sure the patient
received all their prescriptions from only one pharmacy [4].
Patients using medicines from various drug classes were
included because the primary aim of this study was to evaluate
the use of the concordance form followed by a consultation. After
the beginning of the study, it was decided to also study the effecton patient adherence to the medicine. However, the number of
patients included in this study was too small to divide into
comparable groups to assess adherence to different medicines.
The purpose of sending out the questionnaire after 6 months of
use was to see what the main reason was for a patient to stop with
his/her medication. Most patients mentioned side effects as the
reason why they stopped using their medicine or switched to
another medicine. Not all returned questionnaires could be
analysed. Sixty-three percent of the respondents mentioned the
correct name of themedicine they started 6months ago. A possible
explanation could be that the patient had started more than one
medicine at that time. As noted above, the pharmacists mentioned
that some patients also had questions about other medicines they
use, and these medicines were also discussed during the
consultation moment. This could be another explanation for
why the patient mentioned the wrong name of the medicine in the
questionnaire. Because of the low number of analysed ques-
tionnaires, it was not possible to examine the differences in
answers between intervention and control group.
4.2. Conclusion
Pharmacists and patients are positive about the implementa-
tion of the concordance model in Dutch community pharmacies.
The concordance form was found to be a useful tool to start a
patient consultation based on patient needs.
There is no signiﬁcant difference in adherence to medication
between patients in the intervention or control group. However,
the adherence in the control group with 79% is already high. These
results suggest that the use of the concordance form followed by a
consultation at the second dispensing has no signiﬁcant effect on
adherence to chronic drug use.
4.3. Practice implications
Analysis of the written answers on the concordance forms
shows that there are ﬁve questions which provide the most
answers and are considered most relevant. In future studies, it can
be considered that only these ﬁve selected questions instead of the
initial 10 questions on the concordance form shall be used. A
second recommendation is to include only one drug group or select
a larger number of patients so it is possible to divide the patients
into different drug groups. Finally, more consultation moments
during a certain time period is recommended.
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